BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12086477)

  • 1. An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs.
    Szabo CM; Martin MB; Oldfield E
    J Med Chem; 2002 Jul; 45(14):2894-903. PubMed ID: 12086477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates.
    Sanders JM; Gómez AO; Mao J; Meints GA; Van Brussel EM; Burzynska A; Kafarski P; González-Pacanowska D; Oldfield E
    J Med Chem; 2003 Nov; 46(24):5171-83. PubMed ID: 14613320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.
    Sanders JM; Song Y; Chan JM; Zhang Y; Jennings S; Kosztowski T; Odeh S; Flessner R; Schwerdtfeger C; Kotsikorou E; Meints GA; Gómez AO; González-Pacanowska D; Raker AM; Wang H; van Beek ER; Papapoulos SE; Morita CT; Oldfield E
    J Med Chem; 2005 Apr; 48(8):2957-63. PubMed ID: 15828834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
    Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
    J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents.
    Szabo CM; Matsumura Y; Fukura S; Martin MB; Sanders JM; Sengupta S; Cieslak JA; Loftus TC; Lea CR; Lee HJ; Koohang A; Coates RM; Sagami H; Oldfield E
    J Med Chem; 2002 May; 45(11):2185-96. PubMed ID: 12014956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
    Ling Y; Sahota G; Odeh S; Chan JM; Araujo FG; Moreno SN; Oldfield E
    J Med Chem; 2005 May; 48(9):3130-40. PubMed ID: 15857119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents.
    Kotsikorou E; Oldfield E
    J Med Chem; 2003 Jul; 46(14):2932-44. PubMed ID: 12825934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of bisphosphonate inhibition of a vacuolar proton-pumping pyrophosphatase.
    Szabo CM; Oldfield E
    Biochem Biophys Res Commun; 2001 Sep; 287(2):468-73. PubMed ID: 11554752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.
    Sanders JM; Ghosh S; Chan JM; Meints G; Wang H; Raker AM; Song Y; Colantino A; Burzynska A; Kafarski P; Morita CT; Oldfield E
    J Med Chem; 2004 Jan; 47(2):375-84. PubMed ID: 14711309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
    Rogers MJ; Xiong X; Brown RJ; Watts DJ; Russell RG; Bayless AV; Ebetino FH
    Mol Pharmacol; 1995 Feb; 47(2):398-402. PubMed ID: 7870050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum.
    Rogers MJ; Watts DJ; Russell RG; Ji X; Xiong X; Blackburn GM; Bayless AV; Ebetino FH
    J Bone Miner Res; 1994 Jul; 9(7):1029-39. PubMed ID: 7942149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intracellular target for the antiresorptive aminobisphosphonate drugs in Dictyostelium discoideum is the enzyme farnesyl diphosphate synthase.
    Grove JE; Brown RJ; Watts DJ
    J Bone Miner Res; 2000 May; 15(5):971-81. PubMed ID: 10804029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of bisphosphonates against Trypanosoma brucei rhodesiense.
    Martin MB; Sanders JM; Kendrick H; de Luca-Fradley K; Lewis JC; Grimley JS; Van Brussel EM; Olsen JR; Meints GA; Burzynska A; Kafarski P; Croft SL; Oldfield E
    J Med Chem; 2002 Jul; 45(14):2904-14. PubMed ID: 12086478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum.
    Brown RJ; van Beek E; Watts DJ; Löwik CW; Papapoulos SE
    J Bone Miner Res; 1998 Feb; 13(2):253-8. PubMed ID: 9495518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase.
    Szajnman SH; Montalvetti A; Wang Y; Docampo R; Rodriguez JB
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3231-5. PubMed ID: 12951099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human farnesyl pyrophosphate synthase inhibition by nitrogen bisphosphonates: a 3D-QSAR study.
    Fernández D; Ortega-Castro J; Frau J
    J Comput Aided Mol Des; 2013 Aug; 27(8):739-54. PubMed ID: 23979193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of growth of Dictyostelium discoideum amoebae by bisphosphonate drugs is dependent on cellular uptake.
    Rogers MJ; Xiong X; Ji X; Mönkkönen J; Russell RG; Williamson MP; Ebetino FH; Watts DJ
    Pharm Res; 1997 May; 14(5):625-30. PubMed ID: 9165534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation.
    K-M Chen C; Hudock MP; Zhang Y; Guo RT; Cao R; No JH; Liang PH; Ko TP; Chang TH; Chang SC; Song Y; Axelson J; Kumar A; Wang AH; Oldfield E
    J Med Chem; 2008 Sep; 51(18):5594-607. PubMed ID: 18800762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase.
    Thompson K; Dunford JE; Ebetino FH; Rogers MJ
    Biochem Biophys Res Commun; 2002 Jan; 290(2):869-73. PubMed ID: 11785983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition.
    Dunford JE
    Curr Pharm Des; 2010; 16(27):2961-9. PubMed ID: 20722615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.